Cannara Biotech Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
363
- Stock Symbol
-
LOVE
- Investments
-
3
- Share Price
-
$1.40
- (As of Friday Closing)
Cannara Biotech General Information
Description
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
Contact Information
Website
www.cannara.caCorporate Office
- 333 Decarie Boulevard
- Suite 200
- Saint Laurent, Quebec H4N 3M9
- Canada
Corporate Office
- 333 Decarie Boulevard
- Suite 200
- Saint Laurent, Quebec H4N 3M9
- Canada
Cannara Biotech Stock Performance
As of 20-Nov-2026, Cannara Biotech’s stock price is $1.40. Its current market cap is $138M with 98.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.40 | $1.41 | $1.09 - $1.68 | $138M | 98.8M | 38.7K | $0.08 |
Cannara Biotech Financials Summary
As of 31-May-2026, Cannara Biotech has a trailing 12-month revenue of $85.1M.
|
In Thousands, USD |
TTM 31-May-2026 | FY 2025 31-Aug-2025 | FY 2024 31-Aug-2024 | FY 2023 31-Aug-2023 |
|---|---|---|---|---|
| EV | 128,619 | 143,725 | 77,558 | 96,715 |
| Revenue | 85,068 | 76,666 | 60,071 | 42,478 |
| EBITDA | 18,125 | 20,214 | 11,393 | 12,002 |
| Net Income | 7,872 | 9,351 | 4,731 | 5,152 |
| Total Assets | 140,871 | 122,616 | 114,650 | 104,546 |
| Total Debt | 26,799 | 30,232 | 35,811 | 33,821 |
Cannara Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cannara Biotech Signals
Cannara Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cannara Biotech Investments & Acquisitions (3)
Cannara Biotech’s most recent deal was a Merger/Acquisition with Medican Organic for . The deal was made on 05-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Medican Organic | 05-May-2026 | Merger/Acquisition | Cultivation | ||
| Medican Organic (Cultivation and Manufacturing Facility in Valleyfield, Quebec) | 23-Jun-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Global shopCBD.com | 06-Jul-2020 | Merger/Acquisition | Specialty Retail |
Cannara Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Products
Industry
Rank
Percentile
Agriculture
Subindustry
Rank
Percentile
Cannara Biotech Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cannara Biotech (ops) | Saint-Laurent, Canada | 2018 |
Cannara Biotech FAQs
-
When was Cannara Biotech founded?
Cannara Biotech was founded in 2017.
-
Where is Cannara Biotech headquartered?
Cannara Biotech is headquartered in Saint Laurent, Canada.
-
What is the size of Cannara Biotech?
Cannara Biotech has 363 total employees.
-
What industry is Cannara Biotech in?
Cannara Biotech’s primary industry is Cultivation.
-
Is Cannara Biotech a private or public company?
Cannara Biotech is a Public company.
-
What is Cannara Biotech’s stock symbol?
The ticker symbol for Cannara Biotech is LOVE.
-
What is the current stock price of Cannara Biotech?
As of 20-Nov-2026 the stock price of Cannara Biotech is $1.40.
-
What is the current market cap of Cannara Biotech?
The current market capitalization of Cannara Biotech is $138M.
-
What is Cannara Biotech’s current revenue?
The trailing twelve month revenue for Cannara Biotech is $85.1M.
-
What is Cannara Biotech’s annual earnings per share (EPS)?
Cannara Biotech’s EPS for 12 months was $0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process